|
"hsiao l t"的相關文件
顯示項目 11-18 / 18 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:46:58Z |
Haematopoietic stem cell transplantation in Taiwan: Past, present, and future
|
Chen, P.M.;Hsiao, L.T.;Tang, J.L.;Yen, C.C.;Liu, J.H.;Chiou, T.J.;Tzeng, C.H.;Lin, K.H.; KAI-HSIN LIN |
| 國立成功大學 |
2017 |
Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes
|
Chou, W.-C.;Yeh, S.-P.;Hsiao, L.-T.;Lin, S.-F.;Chen, Y.-C.;Chen, T.-Y.;Laille, E.;Galettis, A.;Dong, Q.;Songer, Songer S.;Beach, C.L. |
| 臺大學術典藏 |
2015 |
The board of directors and corporate social performance under weak institutions
|
CHENG-MIN CHUANG; Chuang, C.-M.; Hsiao, L.-T.; Lin, C.-P.; Lin, C.-P.;Hsiao, L.-T.;Chuang, C.-M. |
| 臺大學術典藏 |
2015 |
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
|
Kuo C.-Y.; Hsiao L.-T.; HWEI-FANG TIEN; Wu J.-H.; Hou H.-A.; Wang M.-C.; Liu C.-Y.; Chen P.-M.; Chiou T.-J. |
| 國立成功大學 |
2014-06-01 |
A PHASE 4, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF SUBCUTANEOUS AZACITIDINE IN ADULT TAIWANESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES
|
Chou, W. C.; Yeh, S. P.; Hsiao, L. T.; Lin, S. F.; Chen, Y. C.; Chen, T. Y.; Wang, J. Y.; Galettis, A.; Dong, Q.; Songer, S.; Beach, C. |
| 臺大學術典藏 |
2010 |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
|
Hsu C.-H.; Yang T.-S.; CHIUN HSU; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L. |
| 國立成功大學 |
2002-06 |
Endofem integrated methodology for fatigue crack growth
|
Lee, Chau-Fei; Hsiao, L. T. |
| 國立成功大學 |
2000-12 |
EndoFEM crack closure analysis of AL2024-T3 CCT specimen under all tension fatigue loading
|
Lee, Chau-Fei; Hsiao, L. T. |
顯示項目 11-18 / 18 (共1頁)
1
每頁顯示[10|25|50]項目
|
